Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Venous Disease: Features

Management of Thrombosed Contralateral Common Iliac Vein Secondary to Wallstent Extension Into the Inferior Vena Cava
Case Report
Management of Thrombosed Contralateral Common Iliac Vein Secondary to Wallstent Extension Into the Inferior Vena Cava
04/20/2020
Jailing of the contralateral iliac vein may occur as a result of the iliac vein stent protruding into the IVC. The advent of new, dedicated venous stents with more accurate deployment at the confluence is likely to reduce such a complication.
Jailing of the contralateral iliac vein may occur as a result of the iliac vein stent protruding into the IVC. The advent of new, dedicated venous stents with more accurate deployment at the confluence is likely to reduce such a complication.
Jailing of the contralateral...
04/20/2020
Vascular Disease Management
The Current State of Obstructive Venous Disease
Editor's Corner
The Current State of Obstructive Venous Disease
04/20/2020
Craig Walker, MD, comments on the increase in obstructive venous disease procedures, which remain underdiagnosed and undertreated.
Craig Walker, MD, comments on the increase in obstructive venous disease procedures, which remain underdiagnosed and undertreated.
Craig Walker, MD, comments on...
04/20/2020
Vascular Disease Management
Catheter-Directed Thrombolysis in Submassive Pulmonary Embolism: Safety and Efficacy
Original Research
Catheter-Directed Thrombolysis in Submassive Pulmonary Embolism: Safety and Efficacy
03/09/2020
Golamari et al assessed the applicability of catheter-directed thrombolysis in submassive pulmonary embolism in a community hospital setting. 
Golamari et al assessed the applicability of catheter-directed thrombolysis in submassive pulmonary embolism in a community hospital setting. 
Golamari et al assessed the...
03/09/2020
Vascular Disease Management
PE Response Teams Are Crucial, but Better Prevention Is Needed
Editor's Corner
PE Response Teams Are Crucial, but Better Prevention Is Needed
03/09/2020
Craig Walker, MD, comments on an article addressing catheter-directed thrombolysis in submassive pulmonary embolism.
Craig Walker, MD, comments on an article addressing catheter-directed thrombolysis in submassive pulmonary embolism.
Craig Walker, MD, comments on an...
03/09/2020
Vascular Disease Management
Meeting Exclusives
Retrievable Inferior Vena Cava Filters — Do It
02/24/2020
Jafar Golzarian, MD, and Constantino Peña, MD, spoke in a session dedicated to pulmonary embolism (PE) and filters.
Jafar Golzarian, MD, and Constantino Peña, MD, spoke in a session dedicated to pulmonary embolism (PE) and filters.
Jafar Golzarian, MD, and...
02/24/2020
Vascular Disease Management
Venous Issues
Videos
Treatment of Venous Issues: From Stenting to Prescribing
02/18/2020
Raghu Kolluri, MD, a vascular medicine specialist, discusses deep venous treatment and stenting with Gloria Salazar, MD, an interventional radiologist.
Raghu Kolluri, MD, a vascular medicine specialist, discusses deep venous treatment and stenting with Gloria Salazar, MD, an interventional radiologist.
Raghu Kolluri, MD, a vascular...
02/18/2020
Vascular Disease Management
Venous Stenting
Videos
Benefits of Venous Stenting
02/18/2020
Anthony Comerota, MD, illustrates the benefits of venous stenting by describing a recent case.
Anthony Comerota, MD, illustrates the benefits of venous stenting by describing a recent case.
Anthony Comerota, MD,...
02/18/2020
Vascular Disease Management
Venous Stents: What’s New?
02/18/2020
Case Presentations: The Importance of Percutaneous Crossing to Treat Venous Occlusions
02/14/2020
Case Based: Complex Venocaval Filter Removal
02/14/2020

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement